Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 236

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 6
Chunk 236
---
 and the office holder or a third party in which the office holder has a personal interest, or approve an action by the office holder that would otherwise be deemed a breach of duty of loyalty. However, a company may not approve a transaction or action that is adverse to the company’s interest or that is not performed by the office holder in good faith.
 
A director who has a personal interest in a matter that is considered at a meeting of the board of directors or the audit committee may generally not be present at the meeting or vote on the matter unless a majority of the directors or members of the audit committee have a personal interest in the matter, or, unless the chairman of the audit committee or board of directors (as applicable) determines that he or she should be present to present the transaction that is subject to approval. If a majority of the directors have a personal interest in the matter, such matter also requires approval of the shareholders of the company.
 

Approval of transactions with officer holders
 
Under the Companies Law, unless the articles of association of a company provide otherwise, a transaction with an office holder or with a third party in which the office holder has a personal interest that is not an extraordinary transaction and an action of an office holder that would otherwise be deemed a breach of duty of loyalty that may have a material impact on a company’s profitability, assets or liabilities, requires approval by the board of directors. Our Articles of Association do not provide otherwise. If the transaction or action considered is (i) an extraordinary transaction or (ii) an action of an office holder that would otherwise be deemed a breach of duty of loyalty and may have a material impact on a company’s profitability, assets or liabilities, then audit committee approval is required prior to approval by the board of directors.
 
Approval of compensation of office holders
 

•                                                 Executive officers other than the Chief Executive                                               
             Officer. The compensation of an office holder in a public company who is neither a director nor the chief executive officer          
           generally requires approval by the (i) compensation committee; and (ii) the board of directors. Approval of terms of office and        
     employment for such officers which do not comply with the compensation policy may nonetheless be approved, in special circumstances, subject 
      to two cumulative conditions: (i) the compensation committee and thereafter the board of directors, approved the terms after having taken   
        into account the various considerations and mandatory requirements set forth in the Companies Law with respect a compensation policy,     
       and (ii) the shareholders of the company have approved